Thursday, May 8, 2008

LIVE VIDEO STREAM -- May 8, 2008 -- Rep. Stupak's Oversight of Pharma DTC Hearing


HEARING CONCLUDED -- ARCHIVED VIDEO-STREAM AVAILABLE NOW!
.

UPDATED: 05.08.08 PM -- The Chairman's Opening Statement is now up.

I will have a live, streaming video feed in an embedded window, here, of the entire hearing -- the feed will go "live" at about 9:50 AM EDT, on Thursday May 8, 2008. Be sure to check back, as I've ll updated this post with a full list of witnesses, very likely including a senior Schering-Plough-Merck Joint Venture executive -- but Deepak Khanna (VP & GM MSP J/V) will likely not appear before the luncheon break, as he is on Panel III, the last panel. Do check in on us during the morning -- I'll live-blog any really important updates, in the yellow-box, at lower left. . . .

Feel free to leave your thoughts, questions, etc. as well, there.
Direct-to-Consumer Advertising:
Marketing, Education, or Deception?


[NOTE: You'll need to have
Windows Media Player installed.
]




Subcommittee on Oversight and
Investigations Hearing

10:00 AM EDT, Room 2123

Rayburn House Office Building

WITNESS LIST:

Panel I
Ruth S. Day, Ph.D. -- Statement (PDF File)
Director, Medical Cognition Laboratory
Duke University

Panel II
Mollyann Brodie, Ph.D. -- Statement (PDF File)
Vice President
Director Public Opinion and Media Research
Kaiser Family Foundation

Marcia G. Crosse, Ph.D. -- Statement (PDF File)
Director Health Care
US Government Accountability Office

Nacy H. Nielsen, M.D., Ph.D. -- Statement (PDF File)
President-Elect
American Medical Association

Panel III
Mr. Deepak Khanna -- Statement (PDF File)
Senior Vice President and General Manager,
Merck/Schering-Plough Pharmaceuticals

Mr. James Sage -- Statement (PDF File)
Senior Director/Team Leader, Lipitor
Pfizer, Inc.

Ms. Kim Taylor -- Statement (PDF File)
President,
Ortho Biotech, Inc.,
(A Wholly-owned Subsidiary of)
Johnson & Johnson

By Order of the Chairman:









[At Least One Effect of DTC Advertising?]

1 comment:

condor said...

At the Committee Hearing on DTC Advertising this Thursday, all the pharmaceutical industry "friendly" questions -- and outright defenses -- of Pharma's DTC advertising -- came from one or more of these House Republicans:

Rep. Whitfield (R-KY), who gets significant PAC money (per FEC.gov website) from Abbott, Smith Kline Beecham, Merck, Novartis and Lilly, among others.

Rep. Burgess (R-TX), who gets significant PAC money (per FEC.gov website) from Amgen, HCA, Johnson & Johnson, Merck, Medimmune, Novartis, Roche and Schering-Plough, among others.

Rep. Ferguson (R-NJ), who gets significant PAC money (per FEC.gov website) from Bristol Meyer Squibb, Becton Dickinson, CR Bard, Merck and Johnson & Johnson, among others.

Rep. Barton (R-TX), who gets significant PAC money (per FEC.gov website) from Bayer, among others.

Rep. Shimkus (R-IL), who gets significant PAC money (per FEC.gov website) from Merck, Pfizer, Smith-Kline-Beecham, Novartis and others.

Gee -- that's interesting, no?